McCoy MK et al.(2006) Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinsons disease. J. Neurosci. 26: 9365-9375
[PMID: 16971520]
Interaction Information:
Comment
Blocking soluble TNF signaling with experimental TNF inhibitor called XENP345 in vivo, provides neuroprotection to dopamine neurons from 6-OHDA-induced death.
CIDeR